• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharmaceuticals

Momenta Pharmaceuticals Inc

+ Add to Watchlist


11.7300 USD 0.3000 2.62%

As of 20:10:00 ET on 07/11/2014.

Snapshot for Momenta Pharmaceuticals Inc (MNTA)

Open: 11.4000 Day's Range: 11.4000 - 11.7500 Volume: 357,199
Previous Close: 11.4300 52wk Range: 9.8500 - 19.9000 1-Yr Rtn: -21.28%

Stock Chart for MNTA

No chart data available.
  • MNTA:US 11.7300
  • 1D
  • 1M
  • 1Y
Interactive MNTA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MNTA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -2.1900
Est. EPS (USD) (12/2014) -0.5910
Est. PEG Ratio -
Market Cap (M USD) 618.69
Shares Outstanding (M) 52.74
30 Day Average Volume 542,124
Price/Book (mrq) 2.4974
Price/Sale (ttm) 15.5238
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MNTA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MNTA

Momenta Pharmaceuticals, Inc. is a biotechnology company. The Company specializes in sequencing and engineering of complex sugars for the development of improved versions of existing drugs, the development of novel drugs, and the discovery of new biological processes. Momenta also develops technology-enabled generic products.

Craig A WheelerPresident/CEOMichael FrankenPres:Biosimilars Business/Senior VP
Richard P Shea "Rick"Senior VP/CFOBruce A LeicherSenior VP/Secy/General Cnsl
More Company Profile & Key Executives for MNTA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil